TY  - GEN
AU  - Sanghavi,K
AU  - Brundage,R C
AU  - Miller,M B
AU  - Schladt,D P
AU  - Israni,A K
AU  - Guan,W
AU  - Oetting,W S
AU  - Mannon,R B
AU  - Remmel,R P
AU  - Matas,A J
AU  - Jacobson,P A
TI  - Genotype-guided tacrolimus dosing in African-American kidney transplant recipients
SN  - 1473-1150
PY  - 2017///0731
KW  - Adolescent
KW  - Adult
KW  - Black or African American
KW  - genetics
KW  - Aged
KW  - Calcineurin Inhibitors
KW  - administration & dosage
KW  - Canada
KW  - epidemiology
KW  - Cytochrome P-450 CYP3A
KW  - Drug Dosage Calculations
KW  - Female
KW  - Gene Frequency
KW  - Genotype
KW  - Graft Rejection
KW  - ethnology
KW  - Graft Survival
KW  - drug effects
KW  - Humans
KW  - Immunosuppressive Agents
KW  - Kidney Transplantation
KW  - adverse effects
KW  - Male
KW  - Metabolic Clearance Rate
KW  - Middle Aged
KW  - Models, Genetic
KW  - Pharmacogenetics
KW  - Pharmacogenomic Testing
KW  - Pharmacogenomic Variants
KW  - Phenotype
KW  - Tacrolimus
KW  - Transplant Recipients
KW  - Treatment Outcome
KW  - United States
KW  - Young Adult
N1  - Publication Type: Journal Article; Multicenter Study; Observational Study; Research Support, N.I.H., Extramural
UR  - https://doi.org/10.1038/tpj.2015.87
ER  -